ABSTRACT. Prenatal dexamethasone (DEX) treatment is known to accelerate the maturation of both the surfactant system and the fetal lung antioxidant enzyme (AOE) system (Frank L, Lewis P, Sosenko IRS: Pediatrics 75: [569][570][571][572][573][574] 1985). Because of this stimulatory effect of prenatal DEX on the normal late gestational development of the AOE system, we questioned whether this treatment might have a salutary effect on the ability of the newborn rat to tolerate early and prolonged exposure to hyperoxia, inasmuch as the AOE are the primary lung defensive system against high O 2 challenge. In nine experiments with term newborn rats in >95% O 2 , the composite percentage of survival was significantly greater in the prenatal DEX pups at all time periods in hyperoxia from 7 d [control pups, 67 of 94 (71%); prenatal DEX, 96 of 99 (97%») to 14 d [controls, 10 of 32 (31%); prenatal DEX, 18 of 33 (55%») (p < 0.01). In addition to survival per se, the prenatal DEX pups showed significantly decreased lung wet weight/dry weight ratios, pathologic evidence of pulmonary edema, and lung conjugated dienes versus the O2 control newborn group. Of the many comparative parameters examined, the major difference found between the two groups was in the pulmonary AOE responses to hyperoxia. By 2 d in hyperoxia, the prenatal DEX rat pups showed significantly elevated superoxide dismutase, catalase, and glutathione peroxidase activities compared to air control pups, and at 4 and 7 d in O 2 the AOE levels were consistently greater in the DEX group than the AOE responses in the control O2 pups. The more rapid and more pronounced AOE response to hyperoxic challenge may help to explain the substantial protective effect of prenatal DEX versus newborn O 2 toxicity. immature infant. Administration of a long-acting glucocorticoid for 48 h before premature delivery may successfully stimulate surfactant production/secretion in the immature fetal lung and lessen the chance of serious respiratory distress syndrome in the prematurely delivered newborn (1).
ABSTRACT. Prenatal dexamethasone (DEX) treatment is known to accelerate the maturation of both the surfactant system and the fetal lung antioxidant enzyme (AOE) system (Frank L, Lewis P, Sosenko IRS: Pediatrics 75: [569] [570] [571] [572] [573] [574] 1985) . Because of this stimulatory effect of prenatal DEX on the normal late gestational development of the AOE system, we questioned whether this treatment might have a salutary effect on the ability of the newborn rat to tolerate early and prolonged exposure to hyperoxia, inasmuch as the AOE are the primary lung defensive system against high O 2 challenge. In nine experiments with term newborn rats in >95% O 2 , the composite percentage of survival was significantly greater in the prenatal DEX pups at all time periods in hyperoxia from 7 d [control pups, 67 of 94 (71%); prenatal DEX, 96 of 99 (97%») to 14 d [controls, 10 of 32 (31%); prenatal DEX, 18 of 33 (55%») (p < 0.01). In addition to survival per se, the prenatal DEX pups showed significantly decreased lung wet weight/dry weight ratios, pathologic evidence of pulmonary edema, and lung conjugated dienes versus the O2 control newborn group. Of the many comparative parameters examined, the major difference found between the two groups was in the pulmonary AOE responses to hyperoxia. By 2 d in hyperoxia, the prenatal DEX rat pups showed significantly elevated superoxide dismutase, catalase, and glutathione peroxidase activities compared to air control pups, and at 4 and 7 d in O 2 the AOE levels were consistently greater in the DEX group than the AOE responses in the control O2 pups. The more rapid and more pronounced AOE response to hyperoxic challenge may help to explain the substantial protective effect of prenatal DEX versus newborn O 2 toxicity. (Pediatr Res 32: 215-221, 1992) Abbreviations DEX, dexamethasone AOE, antioxidant enzyme SOD, superoxide dismutase CAT, catalase GP, glutathione peroxidase DSPC, disaturated phosphatidylcholine BPD, bronchopulmonary dysplasia Synthetic glucocorticoids have been used extensively in situations of premature labor with threatened delivery of a very immature infant. Administration of a long-acting glucocorticoid for 48 h before premature delivery may successfully stimulate surfactant production/secretion in the immature fetal lung and lessen the chance of serious respiratory distress syndrome in the prematurely delivered newborn (1).
Previous work from our laboratories has demonstrated that the prenatal administration of DEX to pregnant rats will not only accelerate the late gestational development of the surfactant system in the rat fetuses, but will also accelerate the normal late gestational development of the fetal lung AOE system (2) . The late gestational rise in fetal lung SOD, CAT, and GP activities, now demonstrated to be a natural maturational occurrence in five animal species (rat, mouse, rabbit, hamster, and sheep) (3) (4) (5) (6) (7) (8) , is proposed to be the biochemical means by which the lung is prepared for its safe transition from the quite hypoxic in utero environment to the relatively Os-rich ex utero environment it will encounter immediately at birth (3) (4) (5) 9) .
Because of its marked stimulatory effect on fetal lung AOE system development, we wondered if prenatal DEX treatment might also have a salutary effect on the ability of the newborn animal to tolerate early and prolonged exposure to hyperoxia. We describe herein the findings from a series of hyperoxic exposure experiments that consistently demonstrated an improved resistance to pulmonary O 2 toxicity in the newborn offspring from prenatally DEX-treated dams compared to control newborn rat pups.
MATERIALS AND METHODS
Animals/treatments. We used adult female Sprague-Dawley albino rats (300 g) (originally obtained from Charles River Laboratories, Wilmington, MA), which were in our rat breeding program colonies in the University of Miami Animal Care Facility. Breeding was accomplished by allowing female and male rats to cohabit overnight. Probable pregnancy was determined by a positive sperm smear the next morning, and the onset of gestation was considered to be the midpoint of the 12-h cohabitation period. The length of gestation averages 21.5 d in these animals, with only slight variations (SD = ± 0.23 d) noted in several hundred monitored pregnancies.
At 48 and 24 h before the expected time of delivery, pregnant animals (two or four per experiment) were given intraperitoneal injections of DEX, 0.4 mg/kg/d (dexamethasone sodium phosphate; Henry Schein, Inc., Woodbury, NY) diluted in physiologic saline, or were handled in the exact manner and given intraperitoneal injections of physiologic saline (two or four per experiment). Shortly after delivery, all the newborn pups were removed from the mothers, marked by toe-clipping (DEX or saline pretreated), and pooled together before being randomly redistributed to the newly delivered mother rats, one half of which were then placed in the O 2 exposure chambers and one half of which remained in room air. Litter sizes were 10 to 12 pups per dam.
Exposures to hyperoxia were conducted in clear plastic 3. Biochemical analyses. For lung AOE analysis, some of the experimental pups were killed by an intraperitoneal overdose of pentobarbital after variable periods in hyperoxia or room air. After the great vessels in the abdomen were severed to exsanguinate the animals, their lungs were rapidly perfused in situ with ice-cold isotonic buffer (0.1 M potassium phosphate , 0.15 M potassium chloride, pH 7.4) via the pulmonary artery after removing the left atrial append age for ease of drainage. The dissected lungs were then homogenized in ice-cold 0.005 M potassium phosphate buffer, pH 7.8 (I:20 wt/vol) with a Brinkmann Polytron homogenizer (Brinkmann Instruments, Co., Westbury, NY). SOD activity was measured on fresh homogenates using the spectrophotometric ferricytochrom e reduction method (10) . The crude lung homogenate was centrifuged at IS 000 x g for 10 min at 5°C and the supernatant fluid was remo ved and frozen overnight. CAT activity ( I I) and GP activity (12) in the supernatant fluid were measured spectrophotometrically the next day. The CAT assay monitors the rate of loss of H 202 substrate at 240 nm ; the GP assay follows the rate of NADPH oxidation in the presence of cumene hydroperox ide substrate at 340 nm. Purified enzyme sta ndards were obtained from Sigma Chemical Co., St. Louis, MO (SOD and CAT) and Boehringer Mannheim Co., Indianapolis, IN (GP). Lung protein was determined with purified bovine albumin (Sigma) as standard (13) , and lung DNA was determined with calf thymus DNA (Sigma) as standard (14) . Lung enzyme activity was calculated on the basis of activity per g lung, per mg protein, and per mg DNA, with the latter values used for statistical comparisons because this expression of sp act best reflects the enzyme activity per lung cell, which is what is most meaningful in lung cell protecti ve capacity versus oxidant stress.
For DSPC determinations, aliquots of the homogenates were subjected to lipid extraction using the method of Bligh and Dyer ( 15) . The extract was dried unde r nitrogen, reconstituted with chloroform:methanol (2:I), and assayed for total lipid phosphorus following the method of Morrison (16) . A portion of the dried lipid extract was used to isolate DSPC using the osmium tetroxide method described by Mason et al. (17) and then assayed for inorganic phosphorus as described above (16) . A known qu antity of [1 4C]-dipalmitoylphosphatidylcholine (New England Nuclear, North Billerica, MA) was added before lipid extraction to estimate and correct for sequential losses. DSPC was expressed as mg/g of wet lung weight.
Lung lipid peroxidation was assayed by conjugated diene measurements in air-and Os-exposed rat lungs (18) . This assay in volves homogenizing the perfused lungs in isotonic phosphate buffer containing 0.001 M EDTA. After centrifugation, the homogenate is extracted with 2 volumes of 4SOC meth anol:chloroform (I :2) two times, then once with H20:methan ol: chloroform (I: I:2) After centrifugation , the methanol-HjO upper phase is aspirated off and a 2-mL aliquot of the chloroform extract is dried in a water bath at 40-50°C under N2• The lipid residual is redissolved in 3 mL of heptane and the absorption spectrum at 223 nm is recorded against a heptane blank. Results are expressed as absorbance units per g wet lung and per mg DNA.
Lung elastin was assayed by the spectrophotometric meth od ofNaum and Morgan (19) . After homogenizing the lungs in 0.15 M NaCI and centrifugation , 1.0 mL of 5 M guanidine HCI, pH 7.0, is added to the pellet. Guanidine extraction continues for 24 h at room temperature in a shaking water bath . After centrifugation and a second 24-h extraction with guanidin e, the residue is suspended in 1.0 mL H 20 and then autoclaved at 15 lb pressure for 45 min. After centrifugation, the precipitate is mixed with 1.0 mL H20 and 1.0 mL elastase solution (0. 1 mg purified elastase in 0.1 M veronal acetate buffer, pH 8.8) and incubated for 30 min at 370C in a shaking water bath. Aliquots are then assayed for protein (elastin) content (13) . Purified standards of elastin (Sigma) are treat ed as above for generation of a standard assay curve.
Lung morphometry. For microscopic studies, anim als were killed as above and then had their lungs fixed in situ via a tracheal cannula using a constant inflation pressure of 20 em H 20 (fixative = 10% buffered formalin, pH 7.4). After fixation in the inflated state for 24-48 h, the tissue is processed for hematoxylin and eosin staining. Similarly oriented sections of left lung and right middle and lower lobe are used.
Light level morphometric assessment was done on coded slides for comparison of lung structural development (alveolarization) in air-and Os-exposed neonatal anim als of both experimental groups. We determined mean linear intercept , % air/% tissue space, internal surface area (ISA), and specific internal surface area (ISA/ 100 g body wt) as we have reported previously (20) , using x 450 magnification and an eyepiece with a simple square grid pattern (square grid with seven horizontal lines and 42 intercept bars, model CPLW IOX/ 18 eyepiece; Zeiss Optical, Han over, MD). A minimum of 30 lung fields per anim al were examined. To calculate the mean linear intercept (L M ) (representing the average distance between air space walls, or average airspace diameter), we used the formula LM = n -Lj'ei, where n is the number of lines counted, L is the length of the line, and ei is the sum of septal (walls of air spaces) intercepts. To calculate the ISA, we use the formul a ISA = 4· VL/LM , where VL is the postfixation lung volume by water displacement (21, 22) .
Pathologic assessment was done on additional coded lung sections, looking for evidence of interstitial, periarterial/peribronchiolar edema and intraalveolar edema in the Os-exposed rat lungs. Pulmonary edema was also assessed by lung wet weight/dry weight ratios [80°C oven; lungs dried until constant weight found (48 h)].
Statistical analyses. For quantitative comparisons of the DEX versus control groups, t testing was done. For four group comparisons (control air + O2, DEX air + O2) , one-way analysis of variance testing was done, followed by Duncan's multiple-range testing, using a p < 0.05 value for statistical significance. Survival data were compared for significance using x 2 testing (23). Tables I and  2 provide comparative gravimetric, biochemical, and lung morphometric data on the newborn offspring of the DEX-and salinetreated dams . Prenatal DEX treatment resulted in significantl y reduced body weight and lung weight in the newborn pups as noted before by us and many other investigators (2, (24) (25) (26) . However, the lung weight/body weight ratio was no different than for the control (saline) newborns. Prenatal DEX treatment also resulted in significant reductions in lung protein and DNA content compared to the control group of newborns, but when calculated as mg/g lung weight, the group values were not significantly different.
RESULTS

Prenatal treatm ent effects on newborn offspring.
In this study, as was found in our earlier study (2) , newborn pups of both treatment groups had essentially similar lung surfactant (DSPC) contents as well as AOEactivities (SOD, CAT, and GP) at birth (Fig. I) . Although prenatal DEX treatm ent elevates the levelsofsurfactant and AOE in the premature animal lung, greater than normal full-term lung levels are not found at t he time of birth .
Lung morp hometric analysis of newborn lun g structure (Table  2) showed DEX treatm ent effects on absolute lung volume and lung internal surface area. However, when norm alized to body weight, these values were similar for both experime ntal groups, as were the mean airspace diameters (L M ) . Lun g elastin contents were similarly unchanged in the DEX (0.177 ± 0.015 mg/ lung) versus the contro l pups (0.190 ± 0.003 mg/lung, n = 5 per group , p> 0.10).
S urvival in hype rox ia. In each of nine separate hyperoxia exposure experiments, the prenatal DEX-treated pups dem onstrated a greater percentage of survival than the simultaneously exposed control pups in O 2 • Figure 2 illustrates the composite survival percentages.
Th e DEX-treated pups had significantly improved O 2 toleran ce between exposur e d 7 and 14 inclusive (p < 0.0 I or greater by x 2 testing). In addition to survival per se, the DEX group had other indications of superior O 2 tolerance by comparative lun g wet weight/ dry weight ratios (reflection of pulmo nary edem a), comparative conjugated diene levels (as an index of O 2 radicalinduced lipid peroxid ation), and comparat ive light microscopic pathologic findings (Fig. 3) . The lung wet weight/dry weight ratio averaged 35% higher than the air control value in the Os-saline pups versus 15% higher th an the air control values in the Os-DEX pups ( p < 0.05). Conjugated dienes in the lung were in creased 46% in the Os-saline group versus 11% in the OrDEX pups ( p < 0.05). On light microscopic examination, all the Or exposed pups had perivascular /peribron chiolar edema present after 7 d in Oz. How ever, as evidence of more ad vanc ed Oz toxicity, intraalveolar edema was present in four of 73 (5.5%) Oz-DEX lung sections compared to 38 of 73 (52%) Oz control group lung sections ( p < 0.001) (Fig. 3) .
Lung responses to hyperoxia: The responses of th e surfactant system to 7 d in Oz were very similar in the two treatment groups, with the Oz control group showing a 37 ± 4% increase in lung tissue DSPC content in response to hyperoxia versus a 39 ± 8% increase in the DEX-Oz pup lungs (both values p < 0.05 versus respecti ve air controls). Figure 4 illustrates the comparative responses of the pulmonary AOE to hyperoxic exposure in the two groups of offspring at 2, 4, and 7 d of >95 % O, exposure. The lung morphometri c changes ind uced by prolonged >95% O , exposure in both groups of neonates are shown in Table 3 . The improved survival of the DEX offsprin g in hyp eroxia was not accompanied by an y differences in the degree of Os-indu ced in hibition of normal lung structural maturation (alveolarization and increase in respiratory surface area) th at occurred during hyperoxia. Compared to the air control values, the lun gs of both Oj-exposed groups had significantly enlarged mean airspace diameters and significantly reduced respiratory exchange surface area and surface area l 100 g bod y wt. Figure 5 shows comparative lung micrographs illustrating the marked inhibition of alveolarization in the lungs of both Or exposed groups of pups. Additionally, the typical presence of alveolar edema in th e Oz control group versus the prenatal DEX-O z group is demonstrated in these light-level micrographs.
DISCUSSION
Th e effects of prenatal glucocorti coid treatment on the maturati on of the fetal lung continues to be extensively explored both in vivo and in vitro. Most experime ntal work continues to focus on th e important effect of prenatal glucocorticoid s on accelerating the maturation of the surfactant system (and its associated biosynthetic enz ymes). Newer work has cente red on the effects of glucocorticoids on development changes in the surfactantrelated proteins, SP-A, SP-B, and SP-C (26). This very extensive research effort complements the widespread use of prenatal glucocorticoid treatment in threatened human premature labor to try to stim ulate early surfa ctant production and secretion by the premature fetus and pre vent serious respiratory distress syndrome if premature delivery eventuates.
Newb orn infants who are born too soon, especially those < 1000 g (very low birth weight), are excessively prone to developing earl y and severe lung damage secondary to barotrauma and requ ired high Oz th erap y, which all too often may progre ss to chronic lung disease or BPD . Th e more premature the infant, the more distressingl y high becomes the clinical incidence of BPD (27) . Protection of the lung from the injurious effects of high Oz exposure depends on a variety of known and still unknown factors. Th e pulmonary AOE have been consistently shown to be the primary defensive system against the increased Oz free radicals that are produced in cells under hypero xic conditions (4, 28, 29) .
In the last coupl e of years, som e interesting information has been garn ered that indi cates that in parall el to the developmental profile of th e fetal lung surfactant system in late gestation the AOE system ofthe fetal lung also demonstrates marked increases in activity during the final in utero period before birth. Th is late gestational increase in fetal lung AOE activities has been found to occur in all species examined, including the rat, hamster, guine a pig, rabbit, and sheep (3) (4) (5) (6) (7) (8) . A single report from a small sampling of human infants suggests that late gestational AOE changes in the human fetal lung may also be a norm al ph enomenon (30) . The sim ilar chronology of development of th e fetal " " --------. . . . ----------r ------- * Ten-d-old rat pups from pregnant rats prenatally treat ed at 48 and 24 h before delivery with DEX or equivolume saline. Values are mean ± I SD for n rat lungs per group . Air DEX group values were statistically similar to the air contro l (saline) values shown. LV, lung volume; L M , mean linear intercept (average airspace diameter); and ISA, lung internal surface area. t P < 0.05 for Os-exposed group vs air-controls. lung sur factant and AOE system s suggested that perhaps both systems share common regulatory mechani sms. And, when pregnant rats were administered DE X at 48 and 24 h before delivery, it was found that rat fetuses delivered pre maturely at 20 and 21 d gestatio n (term = 22 d) demonstra ted significantly elevated lu ng levels of DSP C (expected), as well as significantly elevated SOD, CAT, and GP activities (hypothesize d) compared to salinet reated contro l fetu ses (2) .
Because of th is stimulatory effect of prenatal DEX treatment o n th e pro tective AOE system of th e im ma ture lun g, we questioned whether pren atal DEX treatment might result in some m ore prolon ged ben eficial effects on th e ability of th e newborn a nima l to tolerate pro longed hyperoxia. And, as we report herein, t he hyperoxic toleran ce effect of pre na tal DEX treatme nt resulted in superior surv ival of the prenatal DEX-exposed pups in > 95% O2 in nine of nine experi ment s compa red to control newborn ra ts and significantly increased the composite percen tage of survival from d 7 th rou gh 14 of O 2 exposure (Fig. 2) . Simi larly, signs of classic O 2 toxicity includi ng lung edema and associated lipid peroxi datio n were significan tly redu ced in the pr enatal DEX O2 group compared to th e control newb orn s in hyperoxia (Fig. 3) .
To try to explain the basis for the improved O2 tolerance of the prenatally treated DEX pups, we examined a variety of co mparative parameters both at th e time of birth and du ring h yperoxic exposur e. The dat a in Tables 1 and 2 and Figure I fail to prov ide any explanation for th e improve d O 2 tolerance of the p rena tal DEX newborns. T here was no evide nce at th e time of beginning high O2 exposure for any group differences in lun g structural maturation (alveolarization), lung tissue DSP C content, or pulmonary AOE activities.
During exposure to >9 5% O 2 , we found sim ilar increases in lu ng DSPC content in both groups of neo na tes. Similarly, th e quantitat ive morph om etric data, after 10 d in O 2 , showed very similar Oz-ind uced lung alterations in th e two experimental groups . T he inhibi tio n of norm al lung developme nt (alveolarization ) in hyperoxia is considered a growt h-specific effect of high O 2 rather th an a classic path ologic finding. It's believed to be related to th e inhibitory effect of O2 on D NA, prot ein, and elastin synthesis and may occur in early postnatal lun gs that are relatively free of severe O 2 toxicity pat ho logy (3 1).
T he key differen ce that was found between th e prenatal DE X and the saline pu ps in O 2 was in the pu lmonary AOE respo nses ind uced by hyperoxic exposure (Fig. 4) . Although both experimental groups of newborns were ab le to mo u nt an AOE response to O2 challenge, the prenatal DEX pups demon strated an earlier, m ore consiste ntly en hanced AOE response to hyperoxia than the O2 saline pups at each time interval tested. Thus, based on the variou s parameters th at we exami ned, a possible explanation for the significantly im proved O 2 tolera nce of the prenatally DE Xtreated newborns is th e accelerated and increased AOE responsiveness of their lungs to >9 5% O 2 exposur e. Hyperoxia disru pts th e normal oxidant-antioxidant balance in (lung) cells becau se of markedly increased rates of O 2 free radical production (32, 33) . The more rapidly and more completely this oxida nt-an tioxidant imbalance can be resto red to normal by increasi ng th e 220 FRANK Fig. 5 . Light micrographs of lungs of air controls (A), Os-prenatal DEX-treated rats (B), and O, control rats (C). Both groups of'Os-exposed rat pups demonstrate Oz-induced inhibition of normal lung structural development (alveolarization) compared to air controls. The lungs of the pups maintained in air (A) have many small alveolar airspaces apparent compared to the larger, more saccular airspaces of the Os-exposed rat pups (>95% O 2 ; 10 d). In addition, lung of the Oz control group (C) shows evidence of intraalveolar edema, which is absent from lung of O2-prenatal DEX group lungs (B). Original magnification x450; hematoxylin and eosin stain. endogenous antioxidant defenses, the more effectively Os-induced lung injury can be ameliorated. However, even animals with elevated pulmonary AOE may die of progressive lung damage after more prolonged periods in hyperoxia. This is true of newborn rats (including the prenatal DEX treatment group) as well as adult rats treated with exogenous AOE (liposomal SOD, CAT) to extend their survival time in >95% O2• Presumably, the elevated AOE may still be insufficient to detoxify the increased quantity of O 2 radicals generated in >95% O2, and/or specific vital intracellular sites of O2 radical generation or injury (e.g. nuclear DNA) may be inaccessible to the protection offered by increased cytosolic or mitochondrial AOE activity (31, 34, 35) .
Because of the protean nature of glucocorticoid actions, there may be other explanations for why prenatal DEX treatment can protect against the pathologic lung changes associated with hyperoxia (Fig. 3) and improve the survival of newborn rats in hyperoxia. Also, although prenatal DEX treatment results in a persistently more pronounced newborn animal AOE response to hyperoxic challenge, how this response in the postnatal period is mediated by exposure to DEX in the prenatal period is an unanswered question. An interesting study by Schellenberg et al. (36) , who investigated the ontogeny of elastin and collagen development in the late fetal to 30-d-old rat lung, essentially raised this same question. When these investigators tested the effect of prenatal DEX treatment on the normal course of postnatal mesenchymal tissue development, they found that their prenatally DEX-exposed pups showed normal lung elastin contents at birth and at age 5 d, but significant decreases in lung elastin content spanning the period of postnatal d 10 to 20. Because, as in our newborns in O2, this could not possibly be related to exogenous DEX still in the circulation (t'l' = 5 h in the rat), these authors referred in their discussion to the earlier ideas of Davies and Reid (37) that prenatal hormonal treatment can interfere at later times with the normal "developmental program" of the lung. Similarly, delayed onset CNS maturation effects associated with prenatal DEX treatment have recently been discussed in this same vein (38) . Not only DEX, but any exogenous agent that either inhibits or stimulates immature (lung) development may serve to alter some facet of later (lung) development or (lung) responses to stressors (37) .
Finally, one can speculate on the possible meaning of these experimental newborn animal studies of pulmonary O2 toxicity in relation to the clinical situation. Prenatal glucocorticoid treatment for imminent premature birth may actually have a dual beneficial effect in accelerating fetal lung maturation of both the surfactant and the AOE system. The DEX-treated prematurely born infant would thus have an important antioxidant advantage over those equally premature infants born before DEX treatment could be used.
In this light, two recent clinical reports are of interest. These studies specifically looked at whether prenatal glucocorticoid treatment had any effect on the comparative incidence of BPD in treated versus untreated premature newborns (39, 40) . Both reports clearly demonstrated a reduced incidence of BPD in relationship to prenatal glucocorticoid therapy, especially in infants of 1000-1500 g birth weight. Both authors speculate whether surfactant stimulation alone could really account for the reduced incidence of chronic lung disease, suggesting, again, that glucocorticoids may have additional effects on the premature lung including structural changes and diverse biochemical changes, many of which still remain unknown.
Addendum. In view of the large number of reports appearing in the recent pediatric literature about the clinical use of DEX postnatally to try to reduce the incidence and severity of BPD (41) (42) (43) (44) , it is very important to point out here that DEX treatment appears to act very differently on the course ofexperimental pulmonary O 2 toxicity when it is administered prenatally (present studies) than when it is administered postnatally during the period of high O 2 exposure. When used as a treatment agent during hyperoxia, there is very convincing evidence from animal studies in a variety of species that DEX treatment, rather than having a protective effect, in fact tends to markedly accelerate the development of Os-induced lung damage and lethality (31, (45) (46) (47) .
